The claim
What is actually being promised in the community—and what outcome would prove it?
Peptide Atlas / research for lookmaxxing claims
Every peptide claim
gets a proof check.
For people researching skin, hair, body composition, and recovery claims: see the exact molecule, the relevant human outcome, current status, and the gaps nobody put in the caption.
9 compounds mapped12 source-level records9 official/source registers
No products, protocols, supplier links, or paid placements in the research library.
01 Claims are not conclusions
02 Exact identity matters
03 Uncertainty is a finding
The atlas method
One question. Four separate answers.
Most peptide content mixes mechanism, clinical evidence, legal status, and sport rules into a single confident sentence. We pull them apart so you can judge the claim without getting lost in jargon.
The evidence
Human study, animal finding, mechanism, or anecdote? We label the difference.
The status
Jurisdiction, authorisation, and anti-doping are dated questions—not vibes.
The unknowns
We make the gaps visible instead of treating silence as a green light.
The selling point
Stop paying for confidence.
Start with context.
01Know what is actually being studied. A fragment, analogue, formulation, or tissue experiment is not automatically the thing people are talking about online.
02See the study before the conclusion. We show population, question, result, and what the record cannot prove.
03Make the next question smarter. The paid Lookmaxx Peptide Atlas gives a reading order and source path—not a substance plan.
Starter library
Research records, not sales pages.
starter reviewUncertainty is high
BPC-157
Synthetic peptide discussed in injury and recovery communities
A 2025 two-participant safety pilot and a 2026 ex-vivo human-tissue experiment do not test tendon healing or recovery. An older planned phase-I registration has no posted results. No community-claim efficacy conclusion is supported by these records.
Open research recordstarter reviewTested-sport concern
TB-500
Thymosin beta-4 fragment discussed in tissue-repair communities
Do not merge TB-500 with full-length thymosin β4. Recent human studies found in this update concern different thymosin β4 molecules/formulations and unrelated eye or early-phase contexts; they are not evidence for TB-500 or recovery claims.
Open research recordstarter reviewTested-sport concern
CJC-1295
Growth-hormone-releasing hormone analogue
An older randomised study in healthy adults found sustained GH and IGF-I biomarker changes. It did not test muscle gain, fat loss, appearance, performance, recovery, or long-term safety; biomarker change is not a community-claim outcome.
Open research recordA deliberate boundary
Peptide Atlas does not sell peptides, publish sourcing links, create cycles or stacks, or tell anyone what to take. Trust comes from keeping research separate from commerce.